GlaxoSmithKline Consumer Nigeria Plc has declared a Profit After Tax (PAT) of N917 million even as shareholders will receive 55 kobo per share as dividend, a total of N657.7m for the year ended December 2019.
A statement from the company, yesterday, said the company’s annual turnover increased from N18.41 billion in 2018 to N20.76 billion in 2019, representing a 13% growth while PAT rose from N617.62 million to N917.10 million.
Mr. Edmund Onuzo, chairman, board of directors was quoted as saying at the company’s 49th Annual General Meeting (AGM) which held recently that despite 2019 being a challenging year for manufacturers, the company was able to achieve a sustainable performance on all its healthcare portfolio.
“GSK delivered a good performance in 2019 with growth in sales, earnings and strong cash generation,” Onuzo said.
The Managing Director of the firm, Kunle Oyelana, said he was confident in the economic outlook for 2020 while expressing appreciation for the immense support from all stakeholders.
Join Daily Trust WhatsApp Community For Quick Access To News and Happenings Around You.
